Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2025-12-24 @ 7:52 PM
NCT ID:
NCT03243604
Eligibility Criteria:
Inclusion Criteria:
* Case reported in the French pharmacovigilance database from 01/01/1985 to 16/05/2017
* Case reported in the EudraCT database to May 2017
* Adverse event reported were including the MedDRA terms: SOC Cardiac Disorders; SOC Vascular Disorders; HLT Death, Sudden Death; HLGT Water, electrolyte and mineral investigations; HLGT Cardiac and vascular investigations (excl enzyme tests); and PT Syncope.
* Patients treated with hormonal therapies included in the ATC L02, and G03
Exclusion Criteria:
* Chronology not compatible between the drug and the toxicity
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT03243604
Study Brief:
Protocol Section:
NCT03243604